Project Grant HT94252410237
Award Date 6/1/24
Completion Date 5/31/26
Dollars Obligated $481K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Durham, NC 27705, USA
Similar Awards
- Federal Grant Award Summary Duke University's Office of Research Administration received a $960,626 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on August 1, 2025, with a performance period through July 31, 2027. The award supports research into NUAK2 as a novel splicing regulatory kinase in neuroendocrine prostate cancer. This project contributes to the DHA's mission to transform healthcare for service members and...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $700,032 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through July 31, 2029. The award supports research titled "Imaging Strategies and Biomarkers for Detecting the Metabolic Interplay of Glutamine and Aspartate in RCC" (Renal Cell Carcinoma), with work performed at Duke's Durham,...
- The Department of Defense's Defense Health Agency awarded Duke University a $1,344,946 Project Grant on September 1, 2023 through the Military Medical Research and Development program (CFDA 12.420). This grant supports a 3-year research project titled "Understanding Heterogeneity and Improving the Precision of Prostate Cancer Clinical Outcomes in the Modern Era." The research aims to advance understanding and treatment of prostate cancer, with a focus on improving clinical outcomes for...
- The U.S. Defense Health Agency awarded a $1,449,000 Project Grant to Duke University to conduct research aimed at "Identifying Essential Molecular Mechanisms for Advanced Prostate Cancer Growth by a New Chemical Compound." This grant is funded under the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve the health and care of military service members, veterans, and their families. The...
- The Department of the Army Medical Command awarded Duke University a $482,890 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from April 1, 2022 to March 31, 2024 to target the oncogenomic function of the E2F8 transcription factor in lethal prostate cancer. Through this funding, Duke University researchers will investigate medical solutions for prostate cancer at the genomic level, with the aim of transforming healthcare for...
- The U.S. Defense Health Agency awarded a $241,500 Project Grant to Duke University under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "UNDERSTANDING THE MOLECULAR COMMUNICATION BETWEEN PROSTATE CANCER CELL TYPES." The two-year grant, with a performance period from September 1, 2025 to August 31, 2027, will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public....
- Federal Project Grant Award Summary Duke University's Office of Research Administration was awarded $845,250 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) beginning July 1, 2025, through June 30, 2028. The project focuses on engineering T-cell receptor (TCR)-modified T cells designed to target human endogenous retroviruses for non-small cell lung cancer immunotherapy. This research initiative represents an advanced biomedical research...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $724,500.00 to Duke University to conduct research aimed at "TARGETING DORMANCY-ASSOCIATED IMMUNE TOLERANCE TO ELIMINATE RESIDUAL BREAST CANCER." The award period runs from March 1, 2025 to February 29, 2028. As a leading private research institution, Duke University's Office of Research Administration will leverage its multidisciplinary...
- This $161,000 federal Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research at Duke University to investigate "Breast Cancer Brain Metastases: Integrating Immunogenomic and Phenotypic Vulnerabilities to Improve Outcomes." The research aims to develop innovative approaches to understand complex biological systems, create new diagnostic tools, and explore potential therapeutic interventions...
- Duke University's Office of Research Administration received a $1.54M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025 through August 31, 2028. The award funds a clinical research initiative titled "Assessing Prognoses and Validating Surrogate End Points for Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer," to be conducted at the university's Durham, North Carolina...